PR News

Golden Meditech's Associate Company Listed On NYSE Main Board [Fri, Nov 20 2009]
Hong Kong, Nov. 20 /PRNewswire-Asia/ -- China's leading high-tech healthcare group, Golden Meditech Company Limited ("Golden Meditech" or "the Group"; Stock Code: 0801.HK) is pleased to announce today that the Group's associate company China Cord Blood Corporation ("CCBC," NYSE: CO) has been ...

ScinoPharm Announces SafeBridge Potent Compound Safety Certification [Fri, Nov 20 2009]
TAINAN, Taiwan, Nov. 20 /PRNewswire-Asia/ -- ScinoPharm, a leading global supplier of active pharmaceutical ingredients (APIs), announced that its Tainan facility has received the Potent Compound Safety Certification from SafeBridge(R) Consultants, Inc. The Certification confirms ScinoPharm's ...

Golden Meditech's Associate Company Listed On NYSE Main Board [Fri, Nov 20 2009]
Hong Kong, Nov. 20 /PRNewswire-Asia/ -- China's leading high-tech healthcare group, Golden Meditech Company Limited ("Golden Meditech" or "the Group"; Stock Code: 0801.HK) is pleased to announce today that the Group's associate company China Cord Blood Corporation ("CCBC," NYSE: CO) has been ...

NeoStem Outlines To Shareholders Near-term And Long-term Business ... [Fri, Nov 20 2009]
NEW YORK, Nov. 20 /PRNewswire-Asia/ -- NeoStem, Inc. (NYSE Amex: NBS), announced today that it has sent the following letter to its shareholders, discussing the Company's acquisition, on October 30, 2009, of China Biopharmaceuticals Holdings, Inc. (CHBP), an integrated bio-pharmaceutical ...

Jennerex And Lee's Pharmaceuticals Announce Partnership For JX-594 In ... [Wed, Nov 18 2009]
Lee's Will Fund and Manage China Clinical Sites for Jennerex's Pivotal Program and Will Retain Exclusive License Rights in Region SAN FRANCISCO and HONG KONG, Nov. 18 /PRNewswire-Asia/ -- Jennerex, Inc., a clinical-stage biotherapeutics company developing a proprietary breakthrough class of ...

/C O R R E C T I O N -- Education For Health/ [Wed, Nov 18 2009]
In the news release, "Mainstay of the Global Workforce - 40-65 Year Olds - Hit Hardest by Chronic Obstructive Pulmonary Disease (COPD)" issued on 18 Nov 2009 06:30 GMT, by Education for Health over PR Newswire Asia, we are advised by a representative of the company that under "References:" the ...

Mainstay Of The Global Workforce - 40-65 Year Olds - Hit Hardest By ... [Wed, Nov 18 2009]
-- New Report Highlights Global Economic Burden of the Disease -- An Estimated Two Billion Work Hours Lost Each Week LONDON, Nov. 18 / PRNewswire-Asia/ -- COPD Uncovered, a new report issued today reveals for the first time that people between the ages of 40 to 65 are emerging as the new ...

Mesoblast Limited (ASX:MSB) Sustained Six-Month Improvement In Heart ... [Wed, Nov 18 2009]
Melbourne, Nov 18, 2009 (ABN Newswire) - Australia's regenerative medicine company, Mesoblast Limited (ASX:MSB)(PINK:MBLTY), announced today that the first group of patients who received the lowest dose of Revascor(TM), the proprietary "off-the-shelf" adult stem cell product for heart failure, ...

Benitec Limited (ASX:BLT) Chairman Mr Peter Francis Address To Annual ... [Wed, Nov 18 2009]
Melbourne, Nov 18, 2009 (ABN Newswire) - Benitec Limited (ASX:BLT)(PINK:BNIKF) Chairman Mr Peter Francis Address to Annual General Meeting - Welcome and thank you again for your ongoing support. The past financial year has been a demanding one for Benitec. However we look towards a more successful ...

Video: CRESTOR(R) Reduced Risk Of Cardiovascular Events In Women By ... [Wed, Nov 18 2009]
ORLANDO, Fla., Nov. 18 /PRNewswire-Asia/ -- JUPITER, which used CRESTOR 20 mg, is the first statin study to demonstrate a reduction in the risk of cardiovascular (CV) events in women without established cardiovascular disease (CVD). In this new analysis of 6,801 women from the JUPITER study, ...

CRESTOR(R) Reduced Risk Of Cardiovascular Events In Women By Nearly ... [Wed, Nov 18 2009]
ORLANDO, Florida, Nov. 18 /PRNewswire-Asia/ -- JUPITER, which used CRESTOR 20 mg, is the first statin study to demonstrate a reduction in the risk of cardiovascular (CV) events in women without established cardiovascular disease (CVD). In this new analysis of 6,801 women from the JUPITER study, ...

Destination Therapy Trial Data Demonstrate Superiority For HeartMate ... [Tue, Nov 17 2009]
STUDY SHOWS TWO-YEAR SURVIVAL OF 58 PERCENT AND DRAMATIC IMPROVEMENT IN QUALITY OF LIFE FOR HEARTMATE II PATIENTS PLEASANTON, Calif., Nov. 17 /PRNewswire-Asia/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support ...

Sanofi-aventis Launches Major New Registry Including Over 10, 000 ... [Tue, Nov 17 2009]
-- The RealiseAF Registry Will Help to Better Define and Understand the Cardiovascular Risk Profile of AF Patients and Characterize Their Cardiovascular Outcomes PARIS, Nov. 17 /PRNewswire-Asia/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the launch of the RealiseAF ...

Flibanserin Demonstrates Efficacy And Tolerability In Pivotal Phase ... [Mon, Nov 16 2009]
- Results Support Flibanserin as a Potential Treatment for HSDD, an Under-Recognised Women’s Sexual Health Condition - For Medical Media, Outside the US Only INGELHEIM, Germany, Nov. 16 /PRNewswire-Asia/ -- Data from pooled, pivotal Phase III clinical trials demonstrate that ...

GfK Asia Reports: Malaysian Contact Lens Market Sees Strong Recovery ... [Mon, Nov 16 2009]
GfK Asia retail audit of Contact Lens shows market growth of 14% in Malaysia January 2009 to end August 2009 SINGAPORE, Nov. 16 /PRNewswire-Asia/ -- Retail sales of contact lenses within the West Coast of Malaysia grew steadily in the first half of 2009 with total consumption peaking in June, ...

First Global Atrial Fibrillation Registry, RecordAF, Shows ... [Mon, Nov 16 2009]
ORLANDO, Florida, Nov. 16 /PRNewswire-Asia/ -- Results from the RecordAF registry (REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation), presented today at the Scientific Sessions of the American Heart Association, show that in recently diagnosed and actively ...

IVT Will Demo Mobile Health System At GSMA Mobile Asia Congress And ... [Fri, Nov 13 2009]
BEIJING, Nov. 13 /PRNewswire-Asia/ -- IVT Corporation announced today that it will demonstrate its new mobile health system at GSMA Mobile Asia Congress in Hong Kong on Nov. 18-19, at Booth F08, and CES 2010 in Las Vegas. This system allows medical monitoring from home, reducing risk of diseases ...

IVT Will Demo Mobile Health System At GSMA Mobile Asia Congress And ... [Fri, Nov 13 2009]
BEIJING, Nov. 13 /PRNewswire-Asia/ -- IVT Corporation announced today that it will demonstrate its new mobile health system at GSMA Mobile Asia Congress in Hong Kong on Nov. 18-19, at Booth F08, and CES 2010 in Las Vegas. This system allows medical monitoring from home, reducing risk of ...

Shimadzu And EDDA Announce Business Partnership On X-ray Chest CAD ... [Thu, Nov 12 2009]
KYOTO, Japan and PRINCETON, N.J., Nov. 12 /PRNewswire-Asia/ -- Shimadzu Corporation (Kyoto Japan) and EDDA Technology Inc. (Princeton, NJ, USA) today announced that both parties have entered into a business partnership on X-ray chest CAD systems based on the Radiography System of Shimadzu ...

Research On Simbionix PROcedure Rehearsal Software Awarded Magna Cum ... [Wed, Nov 11 2009]
LONDON, Nov. 11 /PRNewswire-Asia/ -- Extensive research conducted by the Imperial College of London, Ghent University Hospital and University of Sheffield on the Simbionix PROcedure Rehearsal Studio(TM), was awarded a Magna Cum Laude EPOS Award at the CIRSE 2009 congress in Lisbon, ...

1 2 3 4 5 6 7 8 9 10 ... 55 Next > Next 10 >>

Service

- XinHua PR Newswire
- ABN Newswire
- ACN Newswire
- YES PR News
Email this page Bookmark and Share